TIANYIN PHARMACEUTICAL CO., INC. - FORM 10-Q - EX-32.2 - CERTIFICATION OF ACTING CHIEF ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (FILED HEREWITH) - February 14, 2013

Attached files

file filename
10-Q - QUARTERLY REPORT - TIANYIN PHARMACEUTICAL CO., INC.f10q1212_tianyin.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER REQUIRED BY RULE 13A-14/15D-14(A) UNDER THE EXCHANGE ACT (FILED HEREWITH) - TIANYIN PHARMACEUTICAL CO., INC.f10q1212ex31i_tianyin.htm
EX-31.2 - CERTIFICATION OF CHIEF ACCOUNTING OFFICER REQUIRED BY RULE 13A-14/15D-14(A) UNDER THE EXCHANGE ACT (FILED HEREWITH) - TIANYIN PHARMACEUTICAL CO., INC.f10q1212ex31ii_tianyin.htm
EXCEL - IDEA: XBRL DOCUMENT - TIANYIN PHARMACEUTICAL CO., INC.Financial_Report.xls
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (FILED HEREWITH) - TIANYIN PHARMACEUTICAL CO., INC.f10q1212ex32i_tianyin.htm
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of Tianyin Pharmaceutical Co., Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report’), I, James Jiayuan Tong, Chief Financial Officer & Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.

Date: February 14, 2013
 
/s/ James Jiayuan Tong
  
 
James Jiayuan Tong
  
 
Chief Financial Officer,
  
 
Director
  

TIANYIN PHARMACEUTICAL CO., INC. Reports